Charlotte Guzzo is the co-founder and COO of Sano Genetics, a healthtech startup that connects patients that have rare and chronic diseases with personalised medicine providers.
Sano Genetics’ platform lets patients with rare and chronic conditions, such as Parkinson’s, contribute to precision medicine research at no cost and from home. It charges a subscription to its pharma, biotech and population health clients.
Its aim is to accelerate the development of treatments for chronic and rare genetic diseases that affect millions of people around the world.
Guzzo founded Sano Genetics in 2017 alongside two fellow postgraduate students of genomics: Patrick Short (CEO) and William Jones (CTO).
The company has raised £11.3m ($14.9m) in funding, including an £8.4m Series A funding round in March 2022, and received several innovation grants. The Cambridge-based company currently employs 45 people....